Preventing the formation of positive transcription elongation factor b by human cyclin T1-binding RNA aptamer for anti-HIV transcription

AIDS

Volumn 26, Issue 13, 2012, Pages 1599-1605

  Um, Hyun Ju ^a   Kim, Mina ^a   Lee, Sang Hee ^a   Kim, Yang Hoon ^a  

^a Chungbuk National University   (South Korea)

Author keywords

aptamer; binding interference; HIV; human cyclin T1; systematic evolution of ligands by exponential enrichment

Indexed keywords

APTAMER; CYCLIN DEPENDENT KINASE 9; CYCLIN T1; TRANSCRIPTION ELONGATION FACTOR;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; COMBINATORIAL CHEMISTRY; DRUG TARGETING; GEL MOBILITY SHIFT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

APTAMERS, NUCLEOTIDE; CYCLIN T; CYCLIN-DEPENDENT KINASE 9; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; RNA, VIRAL; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84865456264     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283554f7d     Document Type: Article

References (20)

1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220:868-871. (Pubitemid 13080157)
2. Saag MS, Hahn BH, Gibbons J, Li Y, Parks ES, Parks WP, et al. Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 1988; 334:440-444.
3. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346:818-822.
4. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505-510.
5. Held DM, Kissel JD, Saran D, Michalowski D, Burke DH. Differential susceptibility of HIV-1 reverse transcriptase to inhibition by RNA aptamers in enzymatic reactions monitoring specific steps during genome replication. J Biol Chem 2006; 281:5712-25722.
6. Puerta-Fernández E, Barroso-del Jesus A, Romero-López C, Tapia N, Martínez MA, Berzal-Herranz A. Inhibition of HIV-1 replication by RNA targeted against the LTR region. AIDS 2005; 19:863-870. (Pubitemid 40834928)
7. Nickens DG, Patterson JT, Burke DH. Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli. RNA 2003; 9:1029-1033. (Pubitemid 37093613)
8. Joshi PJ, North TW, Prasad VR. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication. Mol Ther 2005; 11:677-686. (Pubitemid 40567972)
9. Khati M, Schuman M, Ibrahim J, Sattentau Q, Gordon S, James W. Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers. J Virol 2003; 77:12692-12698. (Pubitemid 37430664)
10. Zhu FX, Biswas EE, Biswas SB. Purification and characterization of the DNA polymerase alpha associated exonuclease: the RTH1 gene product. Biochemistry 1997; 36:5947-5954. (Pubitemid 27257860)
11. Garriga J, Graña X. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 2004; 4:15-23. (Pubitemid 38970101)
12. Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, et al. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 2000; 275:28345-28348.
13. Fujinaga K, Irwin D, Geyer M, Peterlin BM. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression. J Virol 2002; 76:10873-10881. (Pubitemid 35176204)
14. Heredia A, Davis C, Bamba D, Le N, Gwarzo MY, Sadowska M, et al. Indirubin-30-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. AIDS 2005; 19:2087-2095. (Pubitemid 41668996)
15. Mancebo HS, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, et al. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 1997; 11:2633-2644. (Pubitemid 27452387)
16. Hwang S, Tamilarasu N, Kibler K, Cao H, Ali A, Ping YH, et al. Discovery of a small molecule Tattrans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication. J Biol Chem2003; 278:39092-39103.
17. Bai J, Sui J, Zhu RY, Tallarico AS, Gennari F, Zhang D, et al. Inhibition of Tat-mediated transactivation and HIV-1 replication by human antihCyclinT1 intrabodies. J Biol Chem 2003; 278:1433-1442. (Pubitemid 36801368)
18. Napolitano G, Mazzocco A, Fraldi A, Majello B, Lania L. Functional inactivation of Cdk9 through oligomerization chain reaction. Oncogene 2003; 22:4882-4888. (Pubitemid 36981277)
19. Lö fas S, Malmqvist M, Rönnberg I, Stenberg E. Bioanalysis with surface plasmon resonance. Sens Actuators B Chem 1991; 5:79-84.
20. D'Orazio P. Biosensors in clinical chemistry. Clin Chim Acta 2003; 334:41-69. (Pubitemid 36836058)